[Neuroprotective effect of neuroglutam under conditions of activated free radical oxidation]

Eksp Klin Farmakol. 2014;77(8):16-9.
[Article in Russian]

Abstract

The neuroprotective properties of the novel glutamic acid derivative neiroglutam have been studied in vitro and in vivo. Neiroglutam demonstrated the protective action on 6-OH-dopamine neurotoxicity model <MI> in vitro, where free radical oxidation is a basic part of pathogenesis. In control rats, focal brain ischemia caused significant increase in thiobarbituric acid reactive species (TBARS) level and decrease in superoxide dismutase (SOD) enzyme activity. In two-year-old rats, preventive administration of the neiroglutam caused a significant reduction in the TBARS plasma concentration (34.5%, p < 0.05), increased SOD activity, and increased the time of acid-induced hemolysis of erythrocytes (40%, p < 0.05).

Publication types

  • English Abstract

MeSH terms

  • Animals
  • Brain Ischemia / drug therapy*
  • Brain Ischemia / metabolism
  • Brain Ischemia / pathology
  • Cell Line, Tumor
  • Erythrocytes / drug effects
  • Free Radicals / antagonists & inhibitors*
  • Free Radicals / metabolism
  • Glutamic Acid / analogs & derivatives
  • Glutamic Acid / pharmacology*
  • Hemolysis / drug effects
  • Humans
  • Male
  • Neurons / cytology
  • Neurons / drug effects
  • Neurons / metabolism
  • Neuroprotective Agents / pharmacology*
  • Oxidation-Reduction
  • Oxidative Stress
  • Oxidopamine / antagonists & inhibitors
  • Oxidopamine / pharmacology
  • Rats
  • Superoxide Dismutase / metabolism
  • Thiobarbituric Acid Reactive Substances / analysis

Substances

  • Free Radicals
  • Neuroprotective Agents
  • Thiobarbituric Acid Reactive Substances
  • Glutamic Acid
  • Oxidopamine
  • Superoxide Dismutase